Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries - What should work?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 2, 2015, Pages 148-155

  Goldenberg, Robert L ^a   Jones, Bonnie ^b   Griffin, Jennifer B ^b   Rouse, Doris J ^b   Kamath Rayne, Beena D ^c   Trivedi, Nehal ^b   McClure, Elizabeth M ^b  

^a Department of Medicine   (United States)

^b RTI INTERNATIONAL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

eclampsia; magnesium sulfate; maternal mortality; Preeclampsia; sub Saharan Africa

Indexed keywords

MAGNESIUM SULFATE; ANTICONVULSIVE AGENT;

AFRICA SOUTH OF THE SAHARA; CESAREAN SECTION; DEVELOPING COUNTRY; ECLAMPSIA; FEMALE; HOSPITALIZATION; HUMAN; LABOR INDUCTION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATHEMATICAL MODEL; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ADULT; EPIDEMIOLOGY; MORTALITY; PREGNANCY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTICONVULSANTS; CESAREAN SECTION; DEVELOPING COUNTRIES; ECLAMPSIA; FEMALE; HUMANS; LABOR, INDUCED; MAGNESIUM SULFATE; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY;

EID: 84921520323     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12533     Document Type: Review

References (30)

1. Dolea C, AbouZahr C,. Global burden of hypertensive disorders of pregnancy in the year 2000. Geneva: World Health Organization, 2003.
2. Duley L,. The global impact of preeclampsia and eclampsia. Semin Perinatol. 2009; 33: 130-7.
3. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012; 379: 2162-72.
4. Bhutta ZA, Chopra M, Axelson H, Berman P, Boerma T, Bryce J, et al. Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet. 2010; 375: 2032-44.
5. Ghulmiyyah L, Sibai B,. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012; 36: 56-9.
6. Adam GK, Bakheit KH, Adam I,. Maternal and perinatal outcomes of eclampsia in Gadarif Hospital. Sudan. J Obstet Gynaecol. 2009; 29: 619-20.
7. Goldenberg RL, McClure EM, Macguire ER, Kamath BD, Jobe AH,. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet. 2011; 113: 91-5.
8. O'Connor HD, Hehir MP, Kent EM, Foley ME, Fitzpatrick C, Geary MP, et al. Eclampsia: trends in incidence and outcomes over 30 years. Am J Perinatol. 2013; 30: 661-4.
9. Swain S, Ojha KN, Prakash A, Bhatia BD,. Maternal and perinatal mortality due to eclampsia. Indian Pediatr. 1993; 30: 771-3.
10. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF,. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367: 1066-74.
11. Ferrazzani S, Luciano R, Garofalo S, D'Andrea V, De Carolis S, De Carolis MP, et al. Neonatal outcome in hypertensive disorders of pregnancy. Early Hum Dev. 2011; 87: 445-9.
12. Chu K, Cortier H, Maldonado F, Mashant T, Ford N, Trelles M,. Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres. PLoS ONE. 2012; 7: e44484.
13. Jim B, Sharma S, Kebede T, Acharya A,. Hypertension in pregnancy: a comprehensive update. Cardiol Rev. 2010; 18: 178-89.
14. McDonald SD, Lutsiv O, Dzaja N, Duley L,. A systematic review of maternal and infant outcomes following magnesium sulfate for preeclampsia/eclampsia in real-world use. Int J Gynaecol Obstet. 2012; 118: 90-6.
15. Langer A, Villar J, Tell K, Kim T, Kennedy S,. Reducing eclampsia-related deaths-a call to action. Lancet. 2008; 371: 705-6.
16. United Nations. Life-saving commodities. Available at: http://www.everywomaneverychild.org/resources/un-commission-on-life-saving-ommodities/life-saving-commodities (accessed 12 June 2013).
17. Okereke E, Ahonsi B, Tukur J, Ishaku SM, Oginni AB,. Benefits of using magnesium sulphate (MgSO) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria. BMC Res Notes. 2012; 5: 421.
18. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D,. Magnesium sulphate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev. 2010; 11: CD000025.
19. Smyth RM, Spark P, Armstrong N, Duley L,. Magpie Trial in the UK: methods and additional data for women and children at 2 years following pregnancy complicated by preeclampsia. BMC Pregnancy Childbirth. 2009; 9: 15.
20. Dhakal G, Subedi M, Paudel K,. Magnesium sulphate in management of severe preeclampsia and eclampsia. J Nepal Health Res Counc. 2012; 10: 113-7.
21. McClure EM, Rouse DJ, Macguire ER, Jones B, Griffin JB, Jobe AH, et al. The MANDATE model for evaluating interventions to reduce postpartum hemorrhage. Int J Gynaecol Obstet. 2013; 121: 5-9.
22. Maternal and Neonatal Directed Assessment of Technology model. Available at: http://mnhtech.org (accessed 12 June 2013).
23. Rudan I, Gibson J, Kapiriri L, Lansang MA, Hyder AA, Lawn J, et al. Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J. 2007; 48: 595-604.
24. United Nations. Available at: http://www.afro.who.int/ (accessed 28 October 2013).
25. United Nations. Birth registry for Sub-Saharan Africa, 2012. Available at: www.data.un.org (accessed 12 December 2013)
26. Goudar SS, Carlo WA, McClure EM, Pasha O, Patel A, Esamai F, et al. The Maternal and Newborn Health Registry Study of the Global Network for Women's and Children's Health Research. Int J Gynaecol Obstet. 2012; 118: 190-3.
27. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynaecol Obstet. 2004; 85 (Suppl 1): S28-41.
28. Abalos E, Duley L, Steyn DW,. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database System Rev. 2007; 1: CD002252.
29. World Health Organization. WHO recommendations for prevention and treatment of preeclampsia and eclampsia. Geneva: WHO, 2011.
30. Lalani S, Firoz T, Magee LA, Sawchuck D, Payne B, Gordon R, et al. Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists. J Obstet Gynaecol Can. 2013; 35: 215-23.